Alterations of FHIT and P53 genes in keratocystic odontogenic tumor, dentigerous and radicular cyst

Journal of Oral Pathology and Medicine

Volumn 37, Issue 5, 2008, Pages 294-301

  Malčić, Ana ^a   Jukić, Silvana ^a   Anić, Ivica ^a   Pavelić, Božidar ^a   Kapitanović, Sanja ^b   Krušlin, Božo ^c   Pavelić, Krešimir ^b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

FHIT; Keratocystic odontogenic tumor; Odontogenic cyst; p53

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; PARAFFIN; PROTEIN P53; TUMOR MARKER;

ARTICLE; CODON; CONTROLLED STUDY; EXON; FHIT GENE; GENE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ODONTOGENIC CYST; ODONTOGENIC TUMOR; P53 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TERATOMA;

ACID ANHYDRIDE HYDROLASES; ADOLESCENT; ADULT; AGED; APOPTOSIS; CELL PROLIFERATION; DENTIGEROUS CYST; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; JAW CYSTS; JAW NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ODONTOGENIC TUMORS; RADICULAR CYST;

EID: 42149144818     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2007.00622.x     Document Type: Article

References (47)

1. Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996 84 : 587 97.
2. Sozzi G, Veronese ML, Negrini M, et al. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 1996 85 : 17 26.
3. Naylor SL, Johnson BE, Minna JD, Sakaguchi AY. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer. Nature 1987 329 : 451 4.
4. Hibi K, Takahashi T, Yamakawa K, et al. Three distinct regions involved in 3p deletions in human lung cancer. Oncogene 1992 7 : 445 9.
5. Glover TW, Coyle-Morris JF, Li FP, et al. Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14 (FRA3B) in lymphocytes. Cancer Genet Cytogenet 1988 31 : 69 73.
6. Glover TW, Stein CK. Chromosome breakage and recombination at fragile sites. Am J Hum Genet 1988 43 : 265 73.
7. Rassool FV, McKeithan TW, Neilly ME, van Melle E, Espinosa R 3rd., Le Beau MM. Preferential integration of marker DNA into the chromosomal fragile site at 3p14.2: an approach to cloning fragile sites. Proc Natl Acad Sci USA 1991 88 : 6657 61.
8. Negrini M, Monaco C, Vorechovsky I, et al. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 1996 56 : 3173 9.
9. Druck T, Hadaczek P, Fu TB, et al. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 1997 57 : 504 12.
10. Tanimoto K, Hayashi S, Tsuchiya E, et al. Abnormalities of the FHIT gene in human oral carcinogenesis. Br J Cancer 2000 82 : 838 43.
11. Lee JI, Soria JC, Hassan K, et al. Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Cancer Res 2001 61 : 837 41.
12. Rosin MP, Lam WL, Poh C, et al. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res 2002 62 : 6447 50.
13. Sozzi G, Pastorino U, Moiraghi L, et al. Loss of FHIT function in lung cancer and preinvasive bronchial lesions. Cancer Res 1998 58 : 5032 7.
14. Campiglio M, Pekarsky Y, Manard S, Tagliabue E, Pilotti S, Croce CM. FHIT loss of function in human primary breast cancer correlates with advanced stage of the disease. Cancer Res 1999 59 : 3866 9.
15. Connolly DC, Greenspan DL, Wu R, et al. Loss of FHIT expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease. Clin Cancer Res 2000 6 : 3505 10.
16. Matthews CP, Shera K, Kiviat N, McDougall JK. Expression of truncated FHIT transcripts in cervical cancers and in normal human cells. Oncogene 2001 20 : 4665 75.
17. Tokuchi Y, Kobayashi Y, Hayashi S, et al. Abnormal FHIT transcripts found in both lung cancer and normal lung tissue. Genes Chromosomes Cancer 1999 24 : 105 11.
18. Isobe M, Emanuel BS, Givol D, Oren M, Croce CM. Localization of gene for human p53 tumor antigen to band 17q13. Nature 1986 320 : 84 5.
19. Hollstein M, Rice K, Greenblatt MS, et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 1994 22 : 3551 5.
20. Pavelić K. Molecular-genetic base of cancer. In : Samija M, ed. Oncology. Zagreb : Medicinska naklada, 2000 19 25.
21. Ogden GR, Chisholm DM, Kiddie RA, Lane DP. P53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts. J Clin Pathol 1992 45 : 1007 10.
22. Warnakulasuriya KA, Johnson NW. Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma. J Oral Pathol Med 1994 23 : 246 50.
23. Kichi E, Enokiya Y, Muramatsu T, et al. Cell proliferation, apoptosis and apoptosis-related factors in odontogenic keratocysts and in dentigerous cysts. J Oral Pathol Med 2005 43 : 280 6.
24. Agaram NP, Collins BM, Barnes L, et al. Molecular analysis to demonstrate that Odontogenic keratocysts are neoplastic. Arch Pathol Lab Med 2004 128 : 313 7.
25. Ohki K, Kumamoto H, Ichinohasama R, Sato T, Takahashi N, Ooya K. PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts. Int J Oral Maxillofac Surg 2004 33 : 584 92.
26. Stoll C, Stollenwerk C, Riediger D, Mittermayer C, Alfer J. Cytokeratin expression patterns for distinction of odontogenic keratocysts from dentigerous and radicular cysts. J Oral Pathol Med 2005 34 : 558 64.
27. Piattelli A, Fioroni M, Santinelli A, Rubini C. p53 protein expression in odontogenic cysts. J Endod 2001 27 : 459 61.
28. Barnes L, Everson JW, Reichart P, Sidransky D (eds). World Health Organization classification of tumors. Pathology and genetics of head and neck tumors. Lyon : IARC Press, 2005.
29. Li TJ, Browne RM, Prime SS, Paterson IC, Matthews JB. p53 expression in odontogenic keratocyst epithelium. J Oral Pathol Med 1996 25 : 249 55.
30. Levanat S, Kappler R, Hemmerlein B, et al. Analysis of the PTCH1 signaling pathway in ovarian dermoids. Int J Mol Med 2004 14 : 793 9.
31. Tosios KI, Kakarantza-Angelopoulou E, Kapranos N. Immunohistochemical study of bcl-2 protein, Ki-67 antigen and p53 protein in epithelium of glandular odontogenic cysts and dentigerous cysts. J Oral Pathol Med 1999 29 : 139 44.
32. Gall K, Pavelic J, Jadro-Santel D, Poljak M, Pavelic K. DNA amplification by polimerase chain reaction from brain tissues embedded in paraffin. Int J Exp Path 1993 74 : 333 7.
33. Ciulla TA, Sklar RM, Hauser SL. A simple method of DNA purification from peripheral blood. Anal Biochem 1988 174 : 485 8.
34. Pavelic K, Krizanac S, Cacev T, et al. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas. Mol Med 2001 7 : 442 53.
35. Virgilio L, Shuster M, Gollin SM, et al. FHIT gene alteration in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 1996 93 : 9770 5.
36. Berggren P, Steineck G, Adolfsson J, et al. P53 mutations in urinary bladder cancer. Br J Cancer 2001 84 : 1505 11.
37. SAS Institute INC. sas procedures guide, release 6.03 edition. Cary, NC : SAS Institute Inc., 1988 222.
38. Philipsen HP, Reichart PA. Classification of odontogenic tumours. A historical review. J Oral Pathol Med 2006 35 : 525 9.
39. Kumamoto H, Ooya K. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors. J Oral Pathol Med 2007 36 : 198 206.
40. Gomez RS, De Marco L. Possible molecular approach to the treatment of odontogenic keratocyst. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 99 : 527 8.
41. Cavalcanti MG, Veltrini VC, Ruprecht A, Vincent SD, Robinson RA. Squamous-cell carcinoma arising from an odontogenic cyst-the importance of computed tomography in the diagnosis of malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005 100 : 365 8.
42. Carinci F, Palmieri A, Delaiti G, et al. Expression profiling of ameloblastic carcinoma. J Craniofac Surg 2004 15 : 264 9.
43. Chaisuparat R, Coletti D, Kolokythas A, Ord RA, Nikitakis NG. Primary intraosseous odontogenic carcinoma arising in an odontogenic cyst or de novo: a clinicopathologic study of six new cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006 101 : 194 200.
44. Makowski GJ, McGuff S, Van Sickels JE. Squamous call carcinoma in a maxillary odontogenic keratocyst. J Oral Maxillofac Surg 2001 59 : 76 80.
45. Greer RO Jr. The oral cavity. In : Silverberg SG ed. Principles and practice of surgical pathology, Vol. 1, 2nd edn. New York : Churchill Livingstone, 1990 835 94.
46. p53-/- mice. Oncogene 2001 20 : 3235 46.
47. Regezi JA. Odontogenic cysts, odontogenic tumors, fibroosseous, and giant cell lesions of the jaws. Mod Pathol, 2002 15 : 331 41.